Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Fear of cancer recurrence (FCR) is a highly prevalent, disruptive, and under-treated problem for breast cancer survivors. This randomized controlled trial will test the efficacy of group-based Acceptance and Commitment Therapy compared to Cognitive Behavioral Therapy and enhanced usual care for breast cancer survivors suffering from FCR while examining its cost-effectiveness and the mechanisms by which the intervention may work. Study findings will guide the future care of breast cancer survivors with FCR.
Epistemonikos ID: bda0df349c6b7256fddb881830906d284b03f54f
First added on: May 13, 2024